Showing results (101-110 of 148) with videos related to

Sort By:
Pageof 15
The Lancet. Gastroenterology & Hepatology|January 28, 2021
SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statementJames L Alexander, Gordon W Moran, Daniel R Gaya, et al.
Alimentary Pharmacology & Therapeutics|August 29, 2019
Infliximab induction regimens in steroid-refractory acute severe colitis: a multicentre retrospective cohort study with propensity score analysisShaji Sebastian, Sally Myers, Konstantinos Argyriou, et al.
Clinical Pharmacology and Therapeutics|February 16, 2026
Building a Robust Investigator-Initiated Platform: The I-CARE ExperienceJulien Kirchgesner, Laurent Beaugerie, Cédric Baumann, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 19, 2016
Discontinuation of Infliximab in Patients With Ulcerative Colitis Is Associated With Increased Risk of Relapse: A Multinational Retrospective Cohort StudyGionata Fiorino, Pablo Navarro Cortes, Pierre Ellul, et al.
Gut|July 28, 2022
Vaccine escape, increased breakthrough and reinfection in infliximab-treated patients with IBD during the Omicron wave of the SARS-CoV-2 pandemicNicholas A Kennedy, Malik Janjua, Neil Chanchlani, et al.
Therapeutic Advances in Gastroenterology|September 2, 2025
The CROCO (CROhn's Disease COhort Study) - study design and protocolJoana Revés, Anthony Buisson, Johan Burisch, et al.
Frontline Gastroenterology|September 3, 2020
Organisational changes and challenges for inflammatory bowel disease services in the UK during the COVID-19 pandemicNicholas A Kennedy, Richard Hansen, Lisa Younge, et al.
United European Gastroenterology Journal|October 25, 2021
Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases: A European retrospective observational studyLaurent Goessens, Jean-Frédéric Colombel, An Outtier, et al.
Gut|April 27, 2021
Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBDNicholas A Kennedy, Simeng Lin, James R Goodhand, et al.
Journal of Crohn'S & Colitis|September 2, 2021
Adalimumab and Infliximab Impair SARS-CoV-2 Antibody Responses: Results from a Therapeutic Drug Monitoring Study in 11 422 Biologic-Treated PatientsNeil Chanchlani, Simeng Lin, Desmond Chee, et al.
Pageof 15